OA
NXTM

Outfitter Advisors’s NxStage Medical Inc. NXTM Stock Holding History

Outfitter Advisors’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$1.46M Sell
52,190
-8,245
-14% -$221K 0.66% 47
2018
Q1 		$1.5M Sell
60,435
-17,725
-23% -$431K 0.69% 48
2017
Q4 		$1.89M Hold
78,160
– – 0.64% 58
2017
Q3 		$2.16M Buy
78,160
+240
+0.3% +$6.4K 0.76% 50
2017
Q2 		$1.95M Buy
77,920
+22,570
+41% +$559K 0.73% 53
2017
Q1 		$1.49M Buy
55,350
+200
+0.4% +$5.53K 0.56% 63
2016
Q4 		$1.45M Buy
55,150
+700
+1% +$17.3K 0.57% 60
2016
Q3 		$1.36M Sell
54,450
-4,650
-8% -$108K 0.55% 62
2016
Q2 		$1.28M Buy
59,100
+700
+1% +$12.5K 0.55% 57
2016
Q1 		$875K Buy
58,400
+4,100
+8% +$68.7K 0.35% 72
2015
Q4 		$1.19M Hold
54,300
– – 0.48% 66
2015
Q3 		$856K Sell
54,300
-3,950
-7% -$63.3K 0.37% 72
2015
Q2 		$832K Hold
58,250
– – 0.32% 79
2015
Q1 		$1.01M Hold
58,250
– – 0.38% 75
2014
Q4 		$1.04M Hold
58,250
– – 0.4% 73
2014
Q3 		$765K Buy
58,250
+400
+0.7% +$5.39K 0.3% 86
2014
Q2 		$831K Hold
57,850
– – 0.32% 82
2014
Q1 		$737K Sell
57,850
-1,200
-2% -$15.7K 0.29% 83
2013
Q4 		$590K Sell
59,050
-15,250
-21% -$173K 0.23% 87
2013
Q3 		$978K Buy
74,300
+200
+0.3% +$2.62K 0.41% 72
2013
Q2 		$1.06M Buy
+74,100
New +$932K 0.49% 67

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

Outfitter Advisors's NXTM Position: Q2 2018 in Review

Outfitter Advisors reduced its NxStage Medical Inc. (NXTM) stake by 14% in Q2 2018, selling an estimated $221K and leaving 52,190 shares worth $1.46M. The position accounts for 0.66% of the portfolio, ranked #47.

Outfitter Advisors first reported a position in NXTM in Q2 2013 and has held it in 21 quarters since. The position peaked at $2.16M in Q3 2017. 171 funds tracked by Wall St. Rank hold NXTM as of Q2 2018.

  • Outfitter Advisors held 52,190 shares of NxStage Medical Inc. worth $1.46M as of Q2 2018.
  • Outfitter Advisors sold 8,245 NxStage Medical Inc. shares in Q2 2018, an estimated $221K.
  • NxStage Medical Inc. made up 0.66% of Outfitter Advisors's portfolio in Q2 2018, its #47 holding.
  • Outfitter Advisors first reported a position in NxStage Medical Inc. in Q2 2013 and has held it in 21 quarters since.
  • Outfitter Advisors's NxStage Medical Inc. position peaked at $2.16M in Q3 2017.
  • 171 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q2 2018.

Based on Outfitter Advisors's 13F filing for Q2 2018, filed 23 Jul 2018.